Last Updated: 16 Sep 2024
Executive Summary
Apyx Medical Inc. (APYX) is a medical device company that develops, manufactures, and sells cosmetic and surgical devices. The company's stock is currently trading at $1.07, below its 52-week high of $3.95 and above its 52-week low of $0.967. Apyx Medical has a market capitalization of $40.19 million and is headquartered in Clearwater, Florida. The company's latest financial results show revenue of $49.03 million for the trailing twelve months (TTM), a decrease of 0.105% year-over-year. Apyx Medical has a negative EBITDA of $21.67 million and a diluted EPS of -$0.82. The company's trailing PE ratio is negative, and its forward PE ratio is not available. Apyx Medical has a price-to-sales ratio of 0.82, a price-to-book ratio of 2.725, an EV-to-revenue ratio of 0.943, and an EV-to-EBITDA ratio of -5.33. The company's beta is 1.206.
Company Overview
Apyx Medical Inc. was founded in 1997 and is headquartered in Clearwater, Florida. The company develops, manufactures, and sells medical devices for the cosmetic and surgical markets. Apyx Medical's products include laser systems, radiofrequency devices, and other medical devices. The company's products are used in a variety of surgical procedures, including cosmetic surgery, plastic surgery, and dermatology. Apyx Medical sells its products through a network of distributors and dealers in the United States and internationally.
Fundamental Analysis
Apyx Medical's financial performance has been mixed in recent years. The company's revenue has grown slightly in recent years, but its profitability has declined. In 2023, Apyx Medical reported revenue of $49.03 million, a decrease of 0.105% year-over-year. The company's EBITDA was -$21.67 million, and its diluted EPS was -$0.82. Apyx Medical's trailing PE ratio is negative, and its forward PE ratio is not available.
Apyx Medical's financial ratios are also mixed. The company's price-to-sales ratio of 0.82 is below the industry average of 1.00. However, the company's price-to-book ratio of 2.725 is above the industry average of 2.00. Apyx Medical's EV-to-revenue ratio of 0.943 is below the industry average of 1.00, and its EV-to-EBITDA ratio of -5.33 is above the industry average of -4.00.
Technical Analysis
Apyx Medical's stock price has been in a downtrend in recent months. The stock price is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is currently at 30.00, which indicates that the stock is oversold. The stock's moving average convergence divergence (MACD) is currently below its signal line, which indicates that the stock's momentum is negative.
Short Term Outlook
Apyx Medical's stock price is likely to continue to decline in the short term. The stock's technical indicators are bearish, and the company's financial performance has been mixed. Apyx Medical is facing a number of challenges, including competition from larger medical device companies and declining demand for its products.
Long Term Outlook
Apyx Medical's long-term outlook is uncertain. The company's financial performance has been mixed, and its stock price has been in a downtrend in recent months. Apyx Medical is facing a number of challenges, but the company also has a number of opportunities. The company's products are used in a variety of surgical procedures, and the demand for these procedures is expected to grow in the future. Apyx Medical also has a number of new products in development, which could help the company to grow its revenue and profitability in the future.
Analyst Recommendations
Analysts are mixed on Apyx Medical's stock. One analyst has a strong buy rating on the stock, two analysts have a buy rating, two analysts have a hold rating, and zero analysts have a sell or strong sell rating. The average analyst target price for Apyx Medical's stock is $3.13.
